Literature DB >> 26798994

Exploring the unbinding of Leishmania (L.) amazonensis CPB derived-epitopes from H2 MHC class I proteins.

Artur M L Brandt1,2, Paulo Ricardo Batista1, Franklin Souza-Silva3, Carlos Roberto Alves3, Ernesto Raul Caffarena1.   

Abstract

New strategies to control Leishmania disease demand an extensive knowledge about several aspects of infection including the understanding of its molecular events. In murine models, cysteine proteinase B from Leishmania amazonensis promotes regulation of immune response, and fragments from its C-terminus extension (cyspep) can play a decisive role in the host-parasite interaction. The interaction between cyspep-derived peptides and major histocompatibility complex (MHC) proteins is a crucial factor in Leishmania infections. Seven cyspep-derived peptides, previously identified as capable of interacting with H-2 (murine) MHC class I proteins, were studied in this work. We established a protocol to simulate the unbinding of these peptides from the cleft of H-2 receptors. From the simulations, we estimated the corresponding free energy of dissociation (ΔGd ) and described the molecular events that occur during the exit of peptides from the cleft. To test the reliability of this method, we first applied it to a calibration set of four crystallographic MHC/peptide complexes. Next, we explored the unbinding of the seven complexes mentioned above. Results were consistent with ΔGd values obtained from surface plasmon resonance (SPR) experiments. We also identified some of the primary interactions between peptides and H-2 receptors, and we detected three regions of influence for the interaction. This pattern was systematically observed for the peptides and helped determine a minimum distance for the real interaction between peptides and H-2 proteins occurring at ∼ 25 Å.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  H-2 Db, H-2 Kd, H-2 Kk and H-2 Ld haplotypes; Leishmania (Leishmania) amazonensis; free energy surface; immunological epitopes; metadynamics

Mesh:

Substances:

Year:  2016        PMID: 26798994     DOI: 10.1002/prot.24994

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  3 in total

1.  Computational prediction of potential inhibitors for SARS-COV-2 main protease based on machine learning, docking, MM-PBSA calculations, and metadynamics.

Authors:  Isabela de Souza Gomes; Charles Abreu Santana; Leandro Soriano Marcolino; Leonardo Henrique França de Lima; Raquel Cardoso de Melo-Minardi; Roberto Sousa Dias; Sérgio Oliveira de Paula; Sabrina de Azevedo Silveira
Journal:  PLoS One       Date:  2022-04-22       Impact factor: 3.752

2.  A higher flexibility at the SARS-CoV-2 main protease active site compared to SARS-CoV and its potentialities for new inhibitor virtual screening targeting multi-conformers.

Authors:  Rafael E O Rocha; Elton J F Chaves; Pedro H C Fischer; Leon S C Costa; Igor Barden Grillo; Luiz E G da Cruz; Fabiana C Guedes; Carlos H da Silveira; Marcus T Scotti; Alex D Camargo; Karina S Machado; Adriano V Werhli; Rafaela S Ferreira; Gerd B Rocha; Leonardo H F de Lima
Journal:  J Biomol Struct Dyn       Date:  2021-05-10

3.  The potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte response.

Authors:  Manas Ranjan Dikhit; Sushmita Das; Vijaya Mahantesh; Akhilesh Kumar; Ashish Kumar Singh; Budheswar Dehury; Ajaya Kumar Rout; Vahab Ali; Ganesh Chandra Sahoo; Roshan Kamal Topno; Krishna Pandey; V N R Das; Sanjiva Bimal; Pradeep Das
Journal:  Sci Rep       Date:  2018-09-21       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.